The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
DermTech, Inc(NASDAQ:DMTK) 
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and t...
Website: http://www.dermtech.com
Founded: 1996
CEO / Founder: John Dobak, M.D.
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
DermTech Days Payable Outstanding ttm (DPO)
DermTech Days Receivable Outstanding ttm (DSO)
DermTech Days Inventory Outstanding ttm (DIO)
DermTech Op Cashflow Per Share ttm
DermTech Free Cashflow Per Share ttm
DermTech Cash Per Share ttm
DermTech P/S ratio ttm
DermTech (GAAP) P/E ratio ttm
DermTech P/B ratio ttm
No extra charts and metrics for this ticker.